Tradestie Institutional Equity Comparison Engine

ORIC vs LYRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ORIC Overall Edge

ORIC Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Oric Pharmaceuticals, Inc. Common Stock (ORIC) driven by superior Growth & Margin, Momentum & Technical while LYRA counters with relative strength in Options & Structure. Fundamentally, ORIC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus LYRA at N/M Forward P/E and -25032.0% operating margin (-87.2% YoY). In options structure, ORIC sits in BREAKDOWN (36th %ile IV; Dealer Gamma Walls on Pro) against LYRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ORIC N/M vs LYRA N/M Fwd P/E
Growth & Margin Winner ORIC
Op Margin 0.0% vs -25032.0% ยท YoY +0.0% vs -87.2%
Momentum & Technical Winner ORIC
1Y -36.2% vs -94.3% ยท 52W Pos 8% vs 1%
Options & Structure Winner LYRA
BREAKDOWN (36th %ile IV) vs UNCLASSIFIED (N/A IV)
ORIC NASDAQ
Oric Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$7.81
+3.86% 1D
Market Cap $814.7M
1M Return -38.6%
1Y Return -36.24%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 64.0 Mom 60.0
LYRA NASDAQ
Lyra Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.49
-62.5% 1D
Market Cap $2.3M
1M Return -62.5%
1Y Return -94.34%
Forward P/E N/M
Unified AI Score
52.2 / 100 HOLD
Tech 60.0 Fund 56.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ORIC -36.24% LYRA -94.34% Spread: +86.9 pp (ORIC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ORIC TTM Op. Margin: 0.0% LYRA TTM Op. Margin: -25032.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ORIC vs LYRA. Trailing 12-month operating profitability (ORIC 0.0% vs LYRA -25032.0%) and valuation multiples (ORIC N/M vs LYRA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ORIC (6) vs LYRA (1)
Institutional Metric ORIC LYRA Criterion Row Winner
Market Capitalization Scale $814.7M $2.3M Larger Scale ORIC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -87.2% Higher Growth ORIC
Operating Margin (TTM) Profitability 0.0% -25032.0% Higher Margin ORIC
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -39.8% -404.5% Higher ROE ORIC
52-Week Range Position Momentum 8% ($7โ€“$15) 1% ($0โ€“$38) Stronger Trend ORIC
Beta / 30D Volatility Risk Regime 1.32ฮฒ ยท 127% Vol 0.33ฮฒ ยท 248% Vol Lower Realized Risk ORIC
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 52.2 / 100 (HOLD) Higher Composite LYRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ORIC vs LYRA Buy Guide
ORIC BREAKDOWN
63d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ORIC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LYRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LYRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ORIC nor LYRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.